메뉴 건너뛰기




Volumn 110, Issue 1, 2010, Pages 171-181

Retraction to: Concurrent inhibition of NF-κB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer (J Cell Biochem, 2010, 110, (171-181), 10.1002/jcb.22523);Concurrent inhibition of NF-κB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer

Author keywords

3,3 diindolylmethane; COX 2; Erlotinib; Gemcitabine; NF B; Pancreatic cancer

Indexed keywords

3,3' DIINDOYLMETHANE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEMCITABINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG;

EID: 77951718562     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25586     Document Type: Erratum
Times cited : (32)

References (24)
  • 1
    • 30344439138 scopus 로고    scopus 로고
    • Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy
    • DOI 10.1158/1535-7163.MCT-05-0065
    • Ali S, El-Rayes BF, Sarkar FH, Philip PA. 2005. Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy. Mol Cancer Ther 4:1943-1951. (Pubitemid 43056977)
    • (2005) Molecular Cancer Therapeutics , vol.4 , Issue.12 , pp. 1943-1951
    • Ali, S.1    El-Rayes, B.F.2    Sarkar, F.H.3    Philip, P.A.4
  • 2
    • 49849102783 scopus 로고    scopus 로고
    • Apoptosis-inducing effect of erlotinib is potentiated by 3,3′-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer
    • Ali S, Banerjee S, Ahmad A, El-Rayes BF, Philip PA, Sarkar FH. 2008. Apoptosis-inducing effect of erlotinib is potentiated by 3,3′- diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer. Mol Cancer Ther 7:1708-1719.
    • (2008) Mol Cancer Ther , vol.7 , pp. 1708-1719
    • Ali, S.1    Banerjee, S.2    Ahmad, A.3    El-Rayes, B.F.4    Philip, P.A.5    Sarkar, F.H.6
  • 4
    • 43949125509 scopus 로고    scopus 로고
    • A new prostate cancer therapeutic approach: Combination of androgen ablation with COX-2 inhibitor
    • DOI 10.1002/ijc.23481
    • Cai Y, Lee YF, Li G, Liu S, Bao BY, Huang J, Hsu CL, Chang C. 2008. A new prostate cancer therapeutic approach: Combination of androgen ablation with COX-2 inhibitor. Int J Cancer 123:195-201. (Pubitemid 351705209)
    • (2008) International Journal of Cancer , vol.123 , Issue.1 , pp. 195-201
    • Cai, Y.1    Lee, Y.-F.2    Li, G.3    Liu, S.4    Bao, B.-Y.5    Huang, J.6    Hsu, C.-L.7    Chang, C.8
  • 6
    • 36749039760 scopus 로고    scopus 로고
    • Tyrosine kinase inhibitors in non-small cell lung and pancreatic cancer: The emerging role of erlotinib
    • Dediu M, Median D, Alexandru A, Vremes G, Gal C. 2007. Tyrosine kinase inhibitors in non-small cell lung and pancreatic cancer: The emerging role of erlotinib. J BUON 12(Suppl 1): S137-S149. (Pubitemid 350213826)
    • (2007) Journal of B.U.ON. , vol.12 , Issue.SUPPL. 1
    • Dediu, M.1    Median, D.2    Alexandru, A.3    Vremes, G.4    Gal, C.5
  • 7
    • 0032423809 scopus 로고    scopus 로고
    • Epidermal growth factor and its receptor as prognostic indicators in Chinese patients with pancreatic cancer
    • Dong M, Nio Y, Guo KJ, Tamura K, Tian YL, Dong YT. 1998. Epidermal growth factor and its receptor as prognostic indicators in Chinese patients with pancreatic cancer. Anticancer Res 18:4613-4619. (Pubitemid 29042032)
    • (1998) Anticancer Research , vol.18 , Issue.6 B , pp. 4613-4619
    • Dong, M.1    Nio, Y.2    Guo, K.-J.3    Tamura, K.4    Tian, Y.-L.5    Dong, Y.-T.6
  • 8
    • 9444296055 scopus 로고    scopus 로고
    • Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines
    • El-Rayes BF, Ali S, Sarkar FH, Philip PA. 2004. Cyclooxygenase-2- dependent and -independent effects of celecoxib in pancreatic cancer cell lines. Mol Cancer Ther 3:1421-1426. (Pubitemid 39562587)
    • (2004) Molecular Cancer Therapeutics , vol.3 , Issue.11 , pp. 1421-1426
    • El-Rayes, B.F.1    Ali, S.2    Sarkar, F.H.3    Philip, P.A.4
  • 11
    • 0035984590 scopus 로고    scopus 로고
    • 3,3′-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression
    • Hong C, Kim HA, Firestone GL, Bjeldanes LF. 2002. 3,3′- Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 23:1297-1305.
    • (2002) Carcinogenesis , vol.23 , pp. 1297-1305
    • Hong, C.1    Kim, H.A.2    Firestone, G.L.3    Bjeldanes, L.F.4
  • 14
    • 33845950491 scopus 로고    scopus 로고
    • Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity
    • Lev-Ari S, Starr A, Vexler A, Karaush V, Loew V, Greif J, Fenig E, Aderka D, Ben-Yosef R. 2006. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Res 26:4423-4430. (Pubitemid 46031517)
    • (2006) Anticancer Research , vol.26 , Issue.6 B , pp. 4423-4430
    • Lev-Ari, S.1    Starr, A.2    Vexler, A.3    Karaush, V.4    Loew, V.5    Greif, J.6    Fenig, E.7    Aderka, D.8    Ben-Yosef, R.9
  • 15
    • 34548845889 scopus 로고    scopus 로고
    • Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines
    • DOI 10.1080/07357900701359577, PII 782019629
    • Lev-Ari S, Vexler A, Starr A, Shkenazy-Voghera M, Greif J, Aderka D, Ben-Yosef R. 2007. Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Invest 25:411-418. (Pubitemid 47450667)
    • (2007) Cancer Investigation , vol.25 , Issue.6 , pp. 411-418
    • Lev-Ari, S.1    Vexler, A.2    Starr, A.3    Ashkenazy-Voghera, M.4    Greif, J.5    Aderka, D.6    Ben-Yosef, R.7
  • 16
    • 33947198190 scopus 로고    scopus 로고
    • Nuclear factor-kappaB (NFkappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy
    • Logan RM, Gibson RJ, Sonis ST, Keefe DM. 2007. Nuclear factor-kappaB (NFkappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncol 43:395-401.
    • (2007) Oral Oncol , vol.43 , pp. 395-401
    • Logan, R.M.1    Gibson, R.J.2    Sonis, S.T.3    Keefe, D.M.4
  • 17
    • 34247529341 scopus 로고    scopus 로고
    • Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1
    • DOI 10.1158/1078-0432.CCR-06-1574
    • Mohammad RM, Goustin AS, Aboukameel A, Chen B, Banerjee S, Wang G, Nikolovska-Coleska Z, Wang S, Al-Katib A. 2007. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1. Clin Cancer Res 13:2226-2235. (Pubitemid 46649892)
    • (2007) Clinical Cancer Research , vol.13 , Issue.7 , pp. 2226-2235
    • Mohammad, R.M.1    Goustin, A.S.2    Aboukameel, A.3    Chen, B.4    Banerjee, S.5    Wang, G.6    Nikolovska-Coleska, Z.7    Wang, S.8    Al-Katib, A.9
  • 19
    • 1942469354 scopus 로고    scopus 로고
    • Identification of an Autoregulatory Feedback Pathway Involving Interleukin-1alpha in Induction of Constitutive NF-kappaB Activation in Pancreatic Cancer Cells
    • DOI 10.1074/jbc.M309789200
    • Niu J, Li Z, Peng B, Chiao PJ. 2004. Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells. J Biol Chem 279:16452-16462. (Pubitemid 38509343)
    • (2004) Journal of Biological Chemistry , vol.279 , Issue.16 , pp. 16452-16462
    • Niu, J.1    Li, Z.2    Peng, B.3    Chiao, P.J.4
  • 20
    • 0036006453 scopus 로고    scopus 로고
    • 2 , transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy
    • DOI 10.1038/nm0302-289
    • Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. 2002. Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8:289-293. (Pubitemid 34250108)
    • (2002) Nature Medicine , vol.8 , Issue.3 , pp. 289-293
    • Pai, R.1    Soreghan, B.2    Szabo, I.L.3    Pavelka, M.4    Baatar, D.5    Tarnawski, A.S.6
  • 21
    • 25144432015 scopus 로고    scopus 로고
    • Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas
    • DOI 10.1038/modpathol.3800427, PII 3800427
    • Papouchado B, Erickson LA, Rohlinger AL, Hobday TJ, Erlichman C, Ames MM, Lloyd RV. 2005. Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas. Mod Pathol 18:1329-1335. (Pubitemid 41348651)
    • (2005) Modern Pathology , vol.18 , Issue.10 , pp. 1329-1335
    • Papouchado, B.1    Erickson, L.A.2    Rohlinger, A.L.3    Hobday, T.J.4    Erlichman, C.5    Ames, M.M.6    Lloyd, R.V.7
  • 22
    • 35948988561 scopus 로고    scopus 로고
    • Inactivation of NF-kappaB by 3,3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells
    • DOI 10.1158/1535-7163.MCT-07-0336
    • Rahman KM, Ali S, Aboukameel A, Sarkar SH, Wang Z, Philip PA, Sakr WA, Raz A. 2007. Inactivation of NF-kappaB by 3,3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells. Mol Cancer Ther 6:2757-2765. (Pubitemid 350064073)
    • (2007) Molecular Cancer Therapeutics , vol.6 , Issue.10 , pp. 2757-2765
    • Rahman, K.M.W.1    Ali, S.2    Aboukameel, A.3    Sarkar, S.H.4    Wang, Z.5    Philip, P.A.6    Sakr, W.A.7    Raz, A.8
  • 24
    • 0033063774 scopus 로고    scopus 로고
    • The epidermal growth factor receptor and its inhibition in cancer therapy
    • DOI 10.1016/S0163-7258(98)00045-X, PII S016372589800045X
    • Woodburn JR. 1999. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther 82:241-250. (Pubitemid 29255919)
    • (1999) Pharmacology and Therapeutics , vol.82 , Issue.2-3 , pp. 241-250
    • Woodburn, J.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.